The Discounted Cash Flow (DCF) valuation of Ose Immunotherapeutics SA (OSE.PA) is (147,414.26) EUR. With the latest stock price at 2.71 EUR, the upside of Ose Immunotherapeutics SA based on DCF is -5431723.5%.
Based on the latest price of 2.71 EUR and our DCF valuation, Ose Immunotherapeutics SA (OSE.PA) is a sell. selling OSE.PA stocks now will result in a potential gain of 5431723.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.1% | 6.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,143,404.22) - (78,943.36) | (147,414.26) |
| Upside | -42129953.3% - -2908845.6% | -5431723.5% |